Browse Drug Recalls
166 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 166 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 166 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Dec 17, 2020 | HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | fentaNYL 1500 mcg/30 mL (50 mcg/mL), 30 mL Single Dose Syringe, Rx Only, SCA ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Ketamine 100 mg/10mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx On... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Morphine Sulfate 30 mg/30 mL in 0.9% Sodium Chloride (1mg/ml), CII, Rx Only, ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Lidocaine HCl 2% 5 mL, 20 mg/mL, Rx Only, 5 mL syringe, Rx Only, SCA Pharmace... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | SUCcinylcholine Chloride 100 mg/5mL, Rx Only, 5 mL Single Dose Syringe, SCA P... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | neostigmine methylsulfate 5 mg/5 mL, (1mg/ml), Rx Only, 5 mL Single Dose Syr... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Lidocaine HCl 1% 10 mL (10mg/ml), Rx Only, 1 mL Single Dose Syringe, SCA Pha... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Atropine Sulfate Injection, 0.8 mg/2 mL (0.4 mg/mL), 2 mL Single Dose Syringe... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | fentaNYL 100 mcg/2mL Injection for IV or IM Use, 2 mL Single Dose Syringe, CI... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Glycopyrrolate 1 mg/5mL (0.2mg/mL), 5 mL Single Dose Syringe, Rx Only, SCA P... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Esmolol HCl 100 mg/10 mL (10mg/ mL), 10 mL Single Dose Syringe, Rx Only, SCA... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | ePHEDrine Sulfate, 50 mg/5mL in 0.9% Sodium Chloride Injection, 5 mL Single D... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride Injection, (5 mg/mL), R... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | Sodium Citrate 4% 3 mL Anticoagulation Solution (40mg/mL), Rx only, 3 mL Sing... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | fentaNYL 100 mcg/50mL Ropivacaine HCl 0.1% in 0.9% Sodium Chloride 50 mL, 50 ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | PHENYLephrine HCl 5000 mg/50 mL in Sodium Chloride 0.9% (100 mcg/mL) Rx Only,... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | ePHEDrine Sulfate 50 mg/10mL in 0.9% Sodium Chloride Injection, 10 mL Single ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 17, 2020 | HYDROmorphone HCl 10mg/50mL in 0.9% Sodium Chloride Injection, CII, Rx Only, ... | Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integra... | Class II | SCA Pharmaceuticals |
| Dec 14, 2020 | Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dos... | Subpotent drug. | Class II | SCA Pharmaceuticals, Inc. |
| Nov 20, 2020 | Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceutic... | Subpotency: Out-of-specification stability test result for low potency was obtained. | Class III | SCA Pharmaceuticals |
| Jul 29, 2020 | Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Contai... | Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylp... | Class I | SCA Pharmaceuticals |
| Jul 29, 2020 | Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Conta... | Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylp... | Class I | SCA Pharmaceuticals |
| Jul 29, 2020 | Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), ... | Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint. | Class II | SCA Pharmaceuticals |
| Jul 29, 2020 | Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Contai... | Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylp... | Class I | SCA Pharmaceuticals |
| Jul 29, 2020 | Heparin Sodium 10,000 units in 0.9% Sodium Chloride 1000 mL, Single Dose Cont... | Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylp... | Class I | SCA Pharmaceuticals |
| Jun 16, 2020 | Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), ... | Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint. | Class II | SCA Pharmaceuticals |
| Nov 26, 2019 | Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road... | Presence of Foreign Substance: Foreign material found inside the vial (manufacturer). | Class II | SCA Pharmaceuticals, LLC |
| Aug 16, 2019 | Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (conce... | Lack of Assurance of Sterility. | Class II | SCA Pharmaceuticals, LLC |
| Aug 27, 2018 | Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Sing... | Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the... | Class I | SCA Pharmaceuticals, Inc. |
| Jun 29, 2018 | Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic ... | Subpotent Drug: Stability data does not support the current expiration dating of 55 days after co... | Class II | SCA Pharmaceuticals |
| Jun 14, 2018 | Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA P... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Phenylephrine HCL 40 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA ... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Fentanyl (as citrate) 2 mcg/mL + Bupivacaine HCL 0.0625% in 0.9% Sodium Chlor... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Phenylephrine HCL 50 mg in 0.9% Sodium Chloride 250 mL Bag (200 mcg/mL), SCA ... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Norepinephrine Bitartrate 16 mg (64 mcg/mL) in 0.9% Sodium Chloride 250 mL ba... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Fentanyl (as citrate) 10 mcg/mL in 0.9% Sodium Chloride 250 mL bag, SCA Pharm... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Morphine Sulfate 1 mg/mL (preservative free; sulfite free) 2 mL fill 3 mL syr... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Phenylephrine HCL 20 mg in 0.9% Sodium Chloride 250 mL Bag (160 mcg/mL), SCA ... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Phenylephrine HCL 10 mg in 0.9% Sodium Chloride 250 mL Bag (40 mcg/mL), SCA P... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Diltiazem HCL 1 mg/mL in 125 mL 0.9% Sodium Chloride 100 mL bag (total volume... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Jun 14, 2018 | Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag... | Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile a... | Class II | SCA Pharmaceuticals, LLC |
| Feb 22, 2018 | labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Us... | Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indica... | Class III | SCA Pharmaceuticals, LLC. |
| Dec 7, 2017 | Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syring... | Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and bey... | Class II | SCA Pharmaceuticals |
| Oct 19, 2017 | ROCuronium Bromide 10 mg per mL, 5 mL Fill in single dose syringe, (50 mg / 5... | Lack Of Assurance Of Sterility. | Class II | SCA Pharmaceuticals, LLC |
| Oct 19, 2017 | HYDROmorphone HCl 20 mcg / mL BUPIvacaine HCl 0.075% in 0.9% Sodium Chloride ... | Lack Of Assurance Of Sterility. | Class II | SCA Pharmaceuticals, LLC |
| Oct 19, 2017 | Calcium GLUCOnate 2 g added to 0.9% Sodium Chloride 50 mL Bag, Each bag conta... | Lack Of Assurance Of Sterility. | Class II | SCA Pharmaceuticals, LLC |
| Oct 19, 2017 | PHENYLephrine HCl 100 mcg per mL In 0.9% Sodium Chloride 10 mL Fill Volume in... | Lack Of Assurance Of Sterility. | Class II | SCA Pharmaceuticals, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.